JACKSON SQUARE CAPITAL, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1812178
SAN FRANCISCO, CA
Position in REGN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$407,181
+$406 QoQ
Shares Held
527
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JACKSON SQUARE CAPITAL, LLC holds $1,340,179 across 2 Biotechnology names. REGN ranks #2 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRVS |
Corvus Pharmaceuticals, Inc.
|
63,773 | $932,998 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
527 | $407,181 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $407,181 | 527 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $406,775 | 527 | Shares | Sole | 2026-01-21 | |
| 2020-09-30 | $12,874 | 23 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $14,343 | 23 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $12,207 | 25 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||